From the Clinical epidemiology and biostatistics, Faculty of Medicine and Health, Örebro University, Örebro.
Department of Clinical Neuroscience, Karolinska Institutet, Stockholm.
J ECT. 2024 Sep 1;40(3):169-172. doi: 10.1097/YCT.0000000000000983. Epub 2023 Dec 28.
This study aimed to compare the long-term effects of maintenance electroconvulsive therapy (M-ECT) with medication and medication only in patients with depression.
A randomized controlled trial of 1 year of M-ECT with medication or medication only investigated relapse/recurrence among 56 patients in remission after electroconvulsive therapy (ECT) for depression was conducted. The results of the first year are published already and showed a significant advantage of M-ECT with medication.The current study was a long-term follow-up. When the randomized treatment allocation ended, medication was continued in both groups but M-ECT was terminated. Patients were followed for up to 10 years via Swedish national registers until the study endpoint of a new psychiatric diagnosis as an inpatient, suicide, suspected suicide, or death of another cause. Time to relapse was compared between the M-ECT with medication group and the medication-only group using Kaplan-Meier estimates.
The median follow-up time was 6.5 years for the M-ECT and medication group and 3.1 years for the medication-only group. One year after randomization 22 patients remained in the M-ECT and medication group, and 14 patients remained in the medication-only group. Relapse patterns between the treatment groups after the completion of M-ECT seemed to be similar according to visual inspection.
This long-term follow-up study suggests that most of the benefit achieved during the treatment period with M-ECT is maintained over several years, but the small sample size, with accompanying large statistical imprecision, makes the results uncertain. More long-term studies of M-ECT are required.Trial registration: ClinicalTrials.gov identifier: NCT00627887.
本研究旨在比较维持性电抽搐治疗(M-ECT)与药物治疗以及单纯药物治疗在抑郁症患者中的长期疗效。
一项为期 1 年的 M-ECT 联合药物治疗或单纯药物治疗的随机对照试验,共纳入 56 例电抽搐治疗(ECT)后缓解的抑郁症患者,以观察复发/再发情况。第一年的研究结果已经发表,结果显示 M-ECT 联合药物治疗具有显著优势。本研究为长期随访研究。当随机治疗分配结束时,两组均继续使用药物治疗,但停止 M-ECT。通过瑞典国家登记处对患者进行随访,最长随访 10 年,直至出现新的精神科诊断(住院患者、自杀、疑似自杀或其他原因死亡)作为研究终点。使用 Kaplan-Meier 估计比较 M-ECT 联合药物治疗组和单纯药物治疗组之间的复发时间。
M-ECT 联合药物治疗组的中位随访时间为 6.5 年,单纯药物治疗组为 3.1 年。随机分组 1 年后,M-ECT 联合药物治疗组仍有 22 例患者,单纯药物治疗组仍有 14 例患者。根据直观观察,M-ECT 治疗结束后两组的复发模式似乎相似。
这项长期随访研究表明,在 M-ECT 治疗期间获得的大部分益处可维持数年,但由于样本量小,统计精度不高,结果不确定。需要更多的 M-ECT 长期研究。
ClinicalTrials.gov 标识符:NCT00627887。